Parasitic diseases are among the most serious public health problems in developing
countries, causing high mortality and economic burdens. The Trypanosomatidae family …

Improved therapies for tuberculosis will require the careful revision of complex, multi-drug
regimens. In this issue of Cell Systems, Larkins-Ford et al. integrate extensive dose …

Tuberculosis is one of the top 10 causes of death worldwide and the leading cause of death
from a single infectious agent prior to COVID19. Mycobacterium tuberculosis (Mtb) is the …

The treatment of tuberculosis (TB), which kills 1.8 million each year, remains difficult,
especially with the emergence of multidrug resistant strains of Mycobacterium tuberculosis …

Evaluating anti-cancer drugs in vitro is an important aspect of the drug development
pipeline. When evaluating anti-cancer drugs, two different measurements are used: relative …

Mycobacterium tuberculosis (Mtb) is an opportunistic bacterial pathogen that causes
tuberculosis disease (TB) and exerts an extensive burden on global health. The complex …

Mycobacterium tuberculosis is one of the leading causes of death due to a single infectious
pathogen. The evolution and spread of drug resistant strains requires new antibiotics to …

The ability to predict changes in cellular growth rate given variation in gene expression is
critical to interpret disease-causing mutations, engineer biosynthetic pathways, and …

Tuberculosis remains a major cause of human morbidity and mortality, and is caused by
infection with the bacterium Mycobacterium tuberculosis. For thousands of years, M …